Meihua International Medical Technologies Co Return on Equity (ROE) Growth & History (MHUAF)
Meihua International Medical Technologies Co's return on equity was 3.90% for fiscal 2025.
View full Meihua International Medical Technologies Co company overviewMeihua International Medical Technologies Co annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 3.90% | −3.20 pp |
| 2024 | 2024-12-31 | 7.10% | −1.07 pp |
| 2023 | 2023-12-31 | 8.17% | +3.10 pp |
| 2022 | 2022-12-31 | 5.08% | −16.69 pp |
| 2021 | 2021-12-31 | 21.77% | −4.61 pp |
| 2020 | 2020-12-31 | 26.38% | — |
Meihua International Medical Technologies Co return on equity trends
Over the last five fiscal years, Meihua International Medical Technologies Co's return on equity decreased from 26.38% to 3.90%, a change of −22.48 percentage points.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Meihua International Medical Technologies Co source filings ↗